View abstract

This abstract is assigned to sessions

Title

The IOP lowering effect of combined iStent +phacoemulcification in patients with glaucoma: prospective study

Purpose	To assess the IOP lowering effect of iStent insertion at the time of phacoemulsificationcombined in patients with glaucoma and to evaluate the number of topical medication needed to treat adequately the IOP, pre- and postoperatively.
Methods	Prospective study. The first 100 patients who underwent a combined operation were included in this study. The IOP was measured on preop, D1, W1, M1, M3, M6, M12 and further. The number of topical medication was calculated, based on number of different therapeutical molecules.
Results	The follow-up period was between 3 to 18 months. The IOP preop was 25.06 mmHg and postoperatively was 16.8 mmHg after 6 months. A mean reduction in the number of glaucoma medications per patient was 1.3, following iStent implant with phacoemulsification.
Conclusion	Combined iStent + Phacoemulcification is an micro invasive surgery of the high IOP in patients with glaucoma and can be used as a definite or temporary treatment for these patients.
Conflict of interest	No

Authors 1

Last name	HAAGDORENS
Initials	M
Department	Chirec Hospital Group, Delta site
City	Brussels

Authors 2

Last name	BOUSTANI
Initials	G
Department	Chirec Hospital Group, Delta site
City	Brussels

Authors 3

Last name	POURJAVAN
Initials	S
Department	Chirec Hospital Group, Delta site
City	Brussels